Temporal relationship between thromboembolic events and myeloproliferative neoplasm diagnosis: is it associated with mortality risk?

Observational OA: closed CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-10 ⓘ

This retrospective cohort study of 138 myeloproliferative neoplasm patients found that the timing of thromboembolic events relative to diagnosis did not influence mortality, whereas advanced age and danazol use were associated with higher death rates.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-10 · read from full text ⓘ

This retrospective cohort study examined 138 BCR-ABL-negative myeloproliferative neoplasm patients to determine if the timing of thromboembolic events relative to diagnosis affects mortality risk. The researchers classified patients based on whether their index event occurred before, during, or after the MPN diagnosis and analyzed demographic and clinical variables associated with death. Results indicated that while older age and danazol use were independent predictors of higher mortality, the temporal sequence of the thromboembolic event did not significantly influence survival outcomes. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: The aim of this study is to investigate the temporal relationship between the first occurrence of thromboembolic events (TEE) and the timing of myeloproliferative neoplasm (MPN) diagnosis and to determine risk factors for TEE-related mortality in MPN. PATIENTS AND METHODS: A total of 138 BCR-ABL-negative MPN patients with TEE, diagnosed from January 2010 to December 2019, were included in this retrospective cohort. Patients were compared according to mortality and subjects were classified into three groups with respect to having suffered index TEE before, during, or after MPN diagnosis. RESULTS: The mean age of surviving patients was 57.5±13.8, while those who had died had a mean age of 72.0±9.0 (p<0.001). Males represented 56.5% of patients with mortality and 60.9% of those without mortality (p=0.876). TEE was detected in 26.0% of MPN patients, and TEE-related mortality rate was 16.7%. There was no relationship between mortality and the classification of patients according to index TEE (p =0.884). High age (p<0.001) and danazol use (p=0.014) were independently associated with TEE-related mortality. CONCLUSIONS: The temporal relationship between TEE and MPN diagnosis was not found to influence mortality. Older patients and danazol recipients should be considered to have a higher risk of TEE-related mortality.
Full text 2,171 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Objective

The aim of this study is to investigate the temporal relationship between the first occurrence of thromboembolic events (TEE) and the timing of myeloproliferative neoplasm (MPN) diagnosis and to determine risk factors for TEE-related mortality in MPN. PATIENTS AND METHODS: A total of 138 BCR-ABL-negative MPN patients with TEE, diagnosed from January 2010 to December 2019, were included in this retrospective cohort. Patients were compared according to mortality and subjects were classified into three groups with respect to having suffered index TEE before, during, or after MPN diagnosis.

Results

The mean age of surviving patients was 57.5±13.8, while those who had died had a mean age of 72.0±9.0 (p<0.001). Males represented 56.5% of patients with mortality and 60.9% of those without mortality (p=0.876). TEE was detected in 26.0% of MPN patients, and TEE-related mortality rate was 16.7%. There was no relationship between mortality and the classification of patients according to index TEE (p =0.884). High age (p<0.001) and danazol use (p=0.014) were independently associated with TEE-related mortality.

Conclusions

The temporal relationship between TEE and MPN diagnosis was not found to influence mortality. Older patients and danazol recipients should be considered to have a higher risk of TEE-related mortality. Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License To cite this article E. Gulturk, D. Yılmaz, G. Bırce Sonmezoz, M. Dırıl Temporal relationship between thromboembolic events and myeloproliferative neoplasm diagnosis: is it associated with mortality risk? Eur Rev Med Pharmacol Sci Year: 2023 Vol. 27 - N. 11 Pages: 4942-4950 DOI: 10.26355/eurrev_202306_32611 Publication History Published online: 13 Jun 2023

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Myeloproliferative Disorders Myeloproliferative Disorders Myeloproliferative Disorders Myeloproliferative Disorders Neoplasms Neoplasms Thromboembolism Aged Aged, 80 and over Danazol Humans Male Middle Aged Retrospective Studies

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-13T19:56:34.800096+00:00
pubmed
last seen: 2026-10-08T21:40:13.912809+00:00
License: CC0 · commercial use OK